Loading...
Entry LevelFull-timeAgile
Salary Range
$25,500 - $34,500 /year
This salary is estimated based on similar roles. The actual salary may vary.
The Finance Analyst – Inventory Analytics and Reporting contributes to inventory forecast cycles and provides financial expertise around processes and policies governing inventory. The analyst promotes cross-functional collaboration by supporting the Operations Brand Teams for Specialty and Eyecare products and use the Power BI Platform to drive automation and inventory consolidation/reporting improvements. This position rolls up under Operations (Supply Chain) Finance and partners closely with Brand Management, Manufacturing Finance (internal and external), and other Company stakeholders.
Responsibilities
• Lead global inventory reporting cycles and manage templates (Actuals and LBE).
• Assist with preparation of robust slide decks for monthly management reporting covering topics such as unapproved inventory, inventory reserves, and distressed inventory. 
• Be a role model by demonstrating team vision and norms, enabling change, and promoting teamwork.
• Drive inventory governance through adherence to policy and standardization of inventory processes.
• Drive improvements to data integrity, building robust and agile reporting in PowerBI, and process simplification.
• Help drive inventory automation by advancing technologies and functionality enhancements.
• Support business partners globally by providing actionable insight on inventory holdings.
• Participate in Brand Team meetings to learn more about some of our key products and business dynamics which can impact our inventory balances.
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
